4//SEC Filing
Brennan Troyen A 4
Accession 0001127602-21-012693
CIK 0000064803other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:59 PM ET
Size
19.4 KB
Accession
0001127602-21-012693
Insider Transaction Report
Form 4
Brennan Troyen A
Chief Medical Officer
Transactions
- Award
Common Stock
2021-02-01+94,516→ 195,074.059 total - Tax Payment
Common Stock
2021-04-01$74.30/sh−42,855$3,184,127→ 152,219.059 total - Tax Payment
Common Stock
2021-04-01$74.30/sh−1,623$120,589→ 154,174.059 total - Award
Stock Option
2021-04-01$74.30/sh+99,344$7,381,259→ 99,344 totalExercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (99,344 underlying)
Holdings
- 47,937
Stock Option
Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (47,937 underlying) - 112,637
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (112,637 underlying) - 161,605
Stock Option
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (161,605 underlying) - 75,134
Stock Option
Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (75,134 underlying) - 4,805
Common Stock (restricted)
- 53,772
Stock Option
Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (53,772 underlying) - 87,575
Stock Option
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (87,575 underlying)
Footnotes (11)
- [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.
- [F10]The number of shares subject to the option were calculated using a 30-day average price.
- [F11]Options became exercisable in four equal annual installments, commencing 4/1/2021.
- [F2]Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.
- [F3]Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.
- [F4]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
- [F5]Option became exercisable in four equal annual installments, commencing 4/1/2016.
- [F6]Option became exercisable in four equal annual installments, commencing 4/1/2017.
- [F7]Option became exercisable in four equal annual installments, commencing 4/3/2018.
- [F8]Option became exercisable in four equal annual installments, commencing 4/1/2019.
- [F9]Option became exercisable in four equal annual installments, commencing 4/1/2020.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001351402
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:59 PM ET
- Size
- 19.4 KB